<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01856517</url>
  </required_header>
  <id_info>
    <org_study_id>2011PPRC01TURC</org_study_id>
    <nct_id>NCT01856517</nct_id>
  </id_info>
  <brief_title>Upregulation of Alpha-1 Receptors Upon Septic Shock?</brief_title>
  <acronym>CATACHOC</acronym>
  <official_title>Up Regulation of Alpha-1 Receptors Upon Septic Shock ?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Direction Centrale du Service de Santé des Armées</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Direction Centrale du Service de Santé des Armées</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hallmarks of septic shock are hypovolemia and reduced pressor response to endogenous
      noradrenaline. The working hypothesis is that the higher the plasma concentration of
      endogenous noradrenaline will be, the lower the pressor response to exogenous noradrenaline
      will be. This will be tested in patients presenting with septic shock, following state of the
      art management (including repeated assessment of vena cava diameter and compliance, and
      response to dynamic indices of loading) following placebo vs clonidine administration (1
      mcg.kg-1.h-1 over 24 h without bolus) and administration of increasing doses of noradrenaline
      (1 mcg, 2 mcg, etc. up to a delta systolic blood pressure circa 25-30 mm Hg).
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in pressor response to exogenous noradrenaline</measure>
    <time_frame>0 and 24 h</time_frame>
    <description>bolus of exogenous noradrenaline (1 mcg and up) are administered to the patient to evoke an increase in delta systolic blood pressure by 25-30 mm Hg. Administration of increasing dose of noradrenaline is stopped as soon as delta systolic blood pressure has reached 25-30 mm Hg.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in heart rate response to increasing doses of dobutamine (100 mcg and up) to evoke an increase in heart rate up to 20 beats per min.</measure>
    <time_frame>0 and 24 h</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>saline administration over 24 h following full optimization of patient according to current guidelines</description>
  </arm_group>
  <arm_group>
    <arm_group_label>clonidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>clonidine 1 mcg.kg-1.h-1 over 24 h following full optimization of the patient according to current guidelines</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clonidine</intervention_name>
    <arm_group_label>clonidine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients presenting to the CCU with septic shock : SBP&lt;90 mm Hg refractory to volume
             load (&gt;30 ml.kg-1 within 6 h before inclusion) thus in need administration of
             noradrenaline for &gt;1 h (0.1 mcg.kg-1.h-1 i.e. &gt;0.5 mg.h-1/70 kg) to maintain mean
             BP&gt;65 mm Hg.

          -  criteria for sepsis :temperature&gt;38.5 or &lt;36°C ; WBC&gt;12 000 or &lt;4000/ml ; tachypnea
             (&gt;20 cycles par min) or mechanical ventilation ; tachycardia : &gt;90 bpmin

          -  written informed consent by the patient or next of kin or signature by the
             investigators of the form &quot;emergency inclusion&quot;

        Exclusion Criteria:

          -  age&lt;18 ans

          -  pregnancy

          -  mental illness making informed consent impossible

          -  Absence of consent as signed by the patient or next of kin or signature of &quot;emergency
             inclusion form&quot;

          -  individual without social security coverage or participating in another biomedical
             research

          -  Contre-indications to clonidine (uncorrected hypovolemia, sick sinus syndrom, III
             grade AV block)

          -  HR&lt;70 bp/min

          -  pre-exitus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Critical Care Unit, Hopital Desgenettes</name>
      <address>
        <city>Lyon</city>
        <zip>69275</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 19, 2013</study_first_submitted>
  <study_first_submitted_qc>May 16, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 17, 2013</study_first_posted>
  <last_update_submitted>July 26, 2017</last_update_submitted>
  <last_update_submitted_qc>July 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Direction Centrale du Service de Santé des Armées</investigator_affiliation>
    <investigator_full_name>Eric Dardare</investigator_full_name>
    <investigator_title>MD attending physician</investigator_title>
  </responsible_party>
  <keyword>pressor response</keyword>
  <keyword>chronotropic response</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clonidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

